PB-22是一種狡詐家藥物,化學式為C23H22N2O2,它在網絡上作為大麻模擬劑供應,並在2013年於日本的合成大麻產品被發現。[1][2]PB-22在其吲哚環的3號位有酯基,可以被視作一類具有獨特結構的合成大麻素。它在2014年於新西蘭[3]、同年於美國管控。[4][5]

PB-22
法律規範狀態
法律規範
識別資訊
  • 1-Pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester
CAS號1400742-17-7
ChemSpider
UNII
CompTox Dashboard英語CompTox Chemicals Dashboard (EPA)
ECHA InfoCard100.233.114 編輯維基數據鏈接
化學資訊
化學式C23H22N2O2
摩爾質量358.44 g·mol−1
3D模型(JSmol英語JSmol
  • CCCCCN1C=C(C2=CC=CC=C21)C(=O)OC3=CC=CC4=C3N=CC=C4
  • InChI=1S/C23H22N2O2/c1-2-3-6-15-25-16-19(18-11-4-5-12-20(18)25)23(26)27-21-13-7-9-17-10-8-14-24-22(17)21/h4-5,7-14,16H,2-3,6,15H2,1H3
  • Key:ZAVGICCEAOUWFM-UHFFFAOYSA-N

參考文獻

編輯
  1. ^ Uchiyama N, Matsuda S, Kawamura M, Kikura-Hanajiri R, Goda Y. Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products. Forensic Toxicology. 2013, 31 (2): 223–240. S2CID 1279637. doi:10.1007/s11419-013-0182-9. 
  2. ^ Lin M, Ellis B, Eubanks LM, Janda KD. Pharmacokinetic Approach to Combat the Synthetic Cannabinoid PB-22. ACS Chemical Neuroscience. July 2021, 12 (14): 2573–2579. PMID 34254505. S2CID 235808519. doi:10.1021/acschemneuro.1c00360. 
  3. ^ Jones N. Legal highs pulled from shelves. New Zealand Herald. New Zealand Media and Entertainment. 1 May 2014 [18 August 2020]. (原始內容存檔於2017-12-01). 
  4. ^ Behonick G, Shanks KG, Firchau DJ, Mathur G, Lynch CF, Nashelsky M, et al. Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22. Journal of Analytical Toxicology. October 2014, 38 (8): 559–562. PMC 4334789 . PMID 24876364. doi:10.1093/jat/bku048. 
  5. ^ PB-22 and 5F-PB-22 (PDF). DEA, Office of Diversion Control. [2023-11-24]. (原始內容存檔 (PDF)於2024-05-21).